Neuromuscular Electrical Stimulator (NMES) Corporate Medical Policy
Customize your policy alerts
Sign up for bcbsvermont Policy 8.03.VT01 alerts
Get alerted when Policy 8.03.VT01 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage and prior approval for therapeutic and functional neuromuscular electrical stimulation devices and related supplies. Therapeutic NMES may be considered medically necessary for specifically documented disuse atrophy and certain post-stroke rehabilitation uses, while specified functional NMES applications are investigational.
The October 2026 review removed non-applicable procedure and equipment codes from the coding table, including 63650, 63655, 63661-63664, 63685, 63688, 64575, 64580, 64581, 64585, 95970, 95971, L8680-L8683, L8685-L8689, A4560, and E0744.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.